Plant‐Based Anticancer Compounds With a Focus on Breast Cancer
Cancer Reports · 2024
DOI: 10.1002/cnr2.70012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Reports, 2024. Verfasst von Amin Moradi Hasan-Abad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Breast cancer is a common form of cancer among women characterized by the growth of malignant cells in the breast tissue. The most common treatments for this condition include chemotherapy, surgical intervention, radiation therapy, hormone therapy, and biological therapy. The primary issues associated with chemotherapy and radiation therapy are their adverse events and significant financial burden among patients in underdeveloped countries. This highlights the need to explore and develop superior therapeutic options that are less detrimental and more economically efficient. Plants provide an abundant supply of innovative compounds and present a promising new avenue for investigating cancer. Plants and their derivations are undergoing a revolution due to their reduced toxicity, expediency, cost‐effectiveness, safety, and simplicity in comparison to conventional treatment methods. Natural products are considered promising candidates for the development of anticancer drugs, due perhaps to the diverse pleiotropic effects on target events. The effects of plant‐derived products are limited to cancer cells while leaving healthy cells unaffected. Identification of compounds with strong anticancer properties and development of plant‐based medications for cancer treatment might be crucial steps in breast cancer therapy. Although bioactive compounds have potent anticancer properties, they also have drawbacks that need to be resolved before their application in clinical trials and improved for the approved drugs. This study aims to give comprehensive information on known anticancer compounds, including their sources and molecular mechanisms of actions, along with opportunities and challenges in plant‐based anticancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Autoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
- Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Anatomy, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Hossein Motedayyen
Zitieren
APA
Hasan-Abad, A. M., Atapour, A., Sobhani-Nasab, A., Motedayyen, H., & ArefNezhad, R. (2024). Plant‐Based Anticancer Compounds With a Focus on Breast Cancer. Cancer Reports. https://doi.org/10.1002/cnr2.70012
Vancouver
Hasan-Abad AM, Atapour A, Sobhani-Nasab A, Motedayyen H, ArefNezhad R. Plant‐Based Anticancer Compounds With a Focus on Breast Cancer. Cancer Reports. 2024. doi:10.1002/cnr2.70012
BibTeX
@article{HasanAbad2024,
author = {Hasan-Abad, Amin Moradi and Atapour, Amir and Sobhani-Nasab, Ali and Motedayyen, Hossein and ArefNezhad, Reza},
title = {Plant‐Based Anticancer Compounds With a Focus on Breast Cancer},
journal = {Cancer Reports},
year = {2024},
doi = {10.1002/cnr2.70012}
}
EUVIMED